SELLAS Life Sciences Group, Inc. (SLS)

4.03 +0.57 (+16.47%) USD  |  NASDAQ  |  Jan 12, 12:10
More

SELLAS Life Sciences Group EPS Basic from Extraordinaries (Quarterly)

EPS Basic from Extraordinaries (Quarterly) Chart

View EPS Basic from Extraordinaries (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Extraordinaries (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Extraordinaries (Quarterly) Benchmarks

View EPS Basic from Extraordinaries (Quarterly) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. --
Geron Corp. --
Vanda Pharmaceuticals, Inc. --
ADMA Biologics, Inc. --